Effect of GSTM1-polymorphism on disease progression and oxidative stress in HIV infection: Modulation by HIV/HCV co-infection and alcohol consumption

Journal of AIDS and Clinical Research

Volumn 4, Issue 9, 2013, Pages

  Parsons, Mary ^a   Campa, Adriana ^a   Lai, Shenghan ^b   Li, Yinghui ^b   Martinez, Janet Diaz ^a   Murillo, Jorge ^c   Greer, Pedro ^c   Martinez, Sabrina Sales ^a   Baum, Marianna K ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Alcohol consumption; GSTM 1 polymorphism; HIV disease progression; HIV HCV co infection; Oxidative stress

Indexed keywords

EID: 84886073028     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000237     Document Type: Article

References (59)

1. Hulgan T, Gerschenson M (2012) HIV and mitochondria: More than just drug toxicity. J Infect Dis 205: 1769-1771.
2. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
3. Feeney ER, Mallon PW (2010) Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation. Curr Pharm Des 16: 3339-3351.
4. Grinspoon S, Carr A (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352: 48-62.
5. Rodriguez-Nóvoa S, Alvarez E, Labarga P, Soriano V (2010) Renal toxicity associated with tenofovir use. Expert Opin Drug Saf 9: 545-559.
6. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, et al. (2010) Bone disease in HIV infection: A practical review and recommendations for HIV care providers. Clin Infect Dis 51: 937-946.
7. Heaton RK, Clifford DB, Franklin DRJr, Woods SP, Ake C, et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
8. Roumier T, Castedo M, Perfettini JL, Andreau K, Métivier D, et al. (2003) Mitochondrion-dependent caspase activation by the HIV-1 envelope. Biochem Pharmacol 66: 1321-1329.
9. Muthumani K, Choo AY, Hwang DS, Chattergoon MA, Dayes NN, et al. (2003) Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem Biophys Res Commun 304: 583-592.
10. Arnoult D, Petit F, Lelièvre JD, Estaquier J (2003) Mitochondria in HIV-1-induced apoptosis. Biochem Biophys Res Commun 304: 561-574.
11. Muñoz JF, Salmen S, Berrueta LR, Carlos MP, Cova JA, et al. (1999) Effect of human immunodeficiency virus type 1 on intracellular activation and superoxide production by neutrophils. J Infect Dis 180: 206-210.
12. Olivetta E, Pietraforte D, Schiavoni I, Minetti M, Federico M, et al. (2005) HIV-1 Nef regulates the release of superoxide anions from human macrophages. Biochem J 390: 591-602.
13. Gil L, Martínez G, González I, Tarinas A, Alvarez A, et al. (2003) Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 47: 217-224.
14. Morris D, Guerra C, Donohue C, Oh H, Khurasany M, et al. (2012) Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clin Dev Immunol 2012: 734125.
15. Perl A, Banki K (2000) Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease. Antioxid Redox Signal 2: 551-573.
16. Repetto M, Reides C, Gomez Carretero ML, Costa M, Griemberg G, et al. (1996) Oxidative stress in blood of HIV infected patients. Clin Chim Acta 255: 107-117.
17. Baum MK (2000) Role of micronutrients in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr 25 Suppl 1: S49-52.
18. Baum MK, Sales S, Jayaweera DT, Lai S, Bradwin G, et al. (2011) Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami. HIV Med 12: 78-86.
19. Israël N, Gougerot-Pocidalo MA (1997) Oxidative stress in human immunodeficiency virus infection. Cell Mol Life Sci 53: 864-870.
20. Ketterer B (2001) A bird's eye view of the glutathione transferase field. Chem Biol Interact 138: 27-42.
21. Moyer AM, Salavaggione OE, Hebbring SJ, Moon I, Hildebrandt MA, et al. (2007) Glutathione S-transferase T1 and M1: Gene sequence variation and functional genomics. Clin Cancer Res 13: 7207-7216.
22. Rebbeck TR (1997) Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743.
23. Anantharaman D, Samant TA, Sen S, Mahimkar MB (2011) Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol 47: 866-872.
24. Gao LB, Pan XM, Li LJ, Liang WB, Bai P, et al. (2011) Null genotypes of GSTM1 and GSTT1 contribute to risk of cervical neoplasia: An evidence-based meta-analysis. PLoS One 6: e20157.
25. Lear JT, Heagerty AH, Smith A, Bowers B, Payne CR, et al. (1996) Multiple cutaneous basal cell carcinomas: Glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumors numbers and accrual. Carcinogenesis 17: 1891-1896.
26. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, et al. (2011) Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis 32: 1361-1365.
27. Brasch-Andersen C, Christiansen L, Tan Q, Haagerup A, Vestbo J, et al. (2004) Possible gene dosage effect of glutathione-S-transferases on atopic asthma: Using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum Mutat 24: 208-214.
28. Wang CH, Wu SB, Wu YT, Wei YH (2013) Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging. Exp Biol Med (Maywood) 238: 450-460.
29. Glesby MJ, Hoover DR, Raiszadeh F, Lee I, Shi Q, et al. (2009) Oxidant stress in HIV-infected women from the Women's Interagency HIV Study. Antivir Ther 14: 763-769.
30. Rose-Zerilli MJ, Barton SJ, Henderson AJ, Shaheen SO, Holloway JW (2009) Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem 55: 1680-1685.
31. Razavi A, Baghshani MR, Ardabili HM, Andalibi MS, Rahsepar AA, et al. (2013) Obese subjects have significantly higher serum prooxidantantioxidant balance values compared to normal-weight subjects. Clin Lab 59: 257-261.
32. Liu D, Liu Y, Ran L, Shang H, Li D (2013) GSTT1 and GSTM1 polymorphisms and prostate cancer risk in Asians: A systematic review and meta-analysis. Tumour Biol.
33. Wang D, Wang B, Zhai JX, Liu DW, Sun GG (2011) Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: A meta-analysis. Neoplasma 58: 352-359.
34. Economopoulos KP, Sergentanis TN (2010) GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis. Eur J Cancer 46: 1617-1631.
35. Zhang J, Liu H, Yan H, Huang G, Wang B (2013) Null genotypes of GSTM1 and GSTT1 contribute to increased risk of diabetes mellitus: A meta-analysis. Gene 518: 405-411.
36. Suvakov S, Damjanovic T, Stefanovic A, Pekmezovic T, Savic-Radojevic A, et al. (2013) Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. Nephrol Dial Transplant 28: 202-212.
37. Feldman DN, Feldman JG, Greenblatt R, Anastos K, Pearce L, et al. (2009) CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women. AIDS Educ Prev 21: 81-93.
38. Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, et al. (2007) Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: A randomized controlled trial. Arch Intern Med 167: 148-154.
39. Baum MK, Lai S, Sales S, Page JB, Campa A (2010) Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect Dis 50: 1653-1660.
40. Winklhofer-Roob BM, Rock E, Ribalta J, Shmerling DH, Roob JM (2003) Effects of vitamin E and carotenoid status on oxidative stress in health and disease. Evidence obtained from human intervention studies. Mol Aspects Med 24: 391-402.
41. Bunupuradah T, Ubolyam S, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, et al. (2012) Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms. Eur J Clin Nutr 66: 900-905.
42. Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, et al. (1997) Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 56: 31-41.
43. Cirelli A, Ciardi M, de Simone C, Sorice F, Giordano R et al. (1991) Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 24: 211-214.
44. Constans J, Pellegrin JL, Sergeant C, Simonoff M, Pellegrin I, et al. (1995) Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 10: 392.
45. Baum MK, Shor-Posner G, Lai S, Zhang G, Lai H, et al. (1997) High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 15: 370-374.
46. Campa A, Shor-Posner G, Indacochea F, Zhang G, Lai H, et al. (1999) Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 20: 508-513.
47. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, et al. (2003) Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434-439.
48. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, et al. (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88: 4673-4676.
49. Hirashima O, Kawano H, Motoyama T, Hirai N, Ohgushi M, et al. (2000) Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol 35: 1860-1866.
50. Mehta K, Van Thiel DH, Shah N, Mobarhan S (2002) Nonalcoholic fatty liver disease: Pathogenesis and the role of antioxidants. Nutr Rev 60: 289-293.
51. Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, et al. (2008) Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 8: 40.
52. Hayek T, Stephens JW, Hubbart CS, Acharya J, Caslake MJ, et al. (2006) A common variant in the glutathione S transferase gene is associated with elevated markers of inflammation and lipid peroxidation in subjects with diabetes mellitus. Atherosclerosis 184: 404-412.
53. Datta SK, Kumar V, Ahmed RS, Tripathi AK, Kalra OP, et al. (2010) Effect of GSTM1 and GSTT1 double deletions in the development of oxidative stress in diabetic nephropathy patients. Indian J Biochem Biophys 47: 100-103.
54. Ueno T, Watanabe H, Fukuda N, Tsunemi A, Tahira K, et al. (2009) Influence of genetic polymorphisms in oxidative stress related genes and smoking on plasma MDA-LDL, soluble CD40 ligand, E-selectin and soluble ICAM1 levels in patients with coronary artery disease. Med Sci Monit 15: CR341-348.
55. Otto-Knapp R, Jurgovsky K, Schierhorn K, Kunkel G (2003) Antioxidative enzymes in human nasal mucosa after exposure to ozone. Possible role of GSTM1 deficiency. Inflamm Res 52: 51-55.
56. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, et al. (2001) Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 33: 240-247.
57. Persidsky Y, Ho W, Ramirez SH, Potula R, Abood ME, et al. (2011) HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions. Brain Behav Immun 25 Suppl 1: S61-70.
58. Fosslien E (2001) Mitochondrial medicine--molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 31: 25-67.
59. Tripathy MK, Mitra D (2010) Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: Up regulation of Complex-IV subunit COX-II and its possible implications. Apoptosis 15: 28-40.